Johnson & Johnson Q1 FY2025 Earnings Call

Johnson & Johnson (JNJ)

Earnings Call FY2025 Q1 Call date: 2024-05-01 Concluded

Quarter scorecard

Revenue

$21.38B

+2.3% YoY

Diluted EPS

$1.34

Gross margin

69.6%

+1.6 pp YoY

Net income

$3.25B

Innovative Medicine $13.56B

+1.1%

MedTech $7.82B

+4.5%

Buybacks

$1.48B